Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated alpha-synuclein. Prasinezumab has the potential for Parkinsons disease research[1].
Molecular Weight:
(145.26 kDa)
Purity:
99.90
CAS Number:
[1960462-19-4]
Target:
alpha-synuclein
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted